Pilot study led by UF neurologists showed that biphasic DBS was safe, well tolerated and may provide faster benefit for patients with primary dystonia.
Normal Fixel Institute one of three in Florida and 56 nationwide to receive renewal.
Drs. Coralie de Hemptinne and Barry Setlow received recognition for their research and mentorship accomplishments.
Researchers designed an AI system that can predict which patients will develop Alzheimer’s up to five years before receiving a diagnosis.
Dr. Michael Okun commented for HealthDay article about a new study looking into pollution’s impact on Parkinson’s diagnoses.
Neuromedicine and neuroscience research at UF ranked Top 5 among all universities (public and private) in the 2022 rankings of NIH funding.
SfN conference included a 53-poster competition, a data blitz and a panel discussion on careers in science, academia and industry.
Lauren Kenney and Adrianna Ratajska are recipients of the Ruth L. Kirschstein Predoctoral Individual National Research Service Award.
UF study finds evoked resonant neural activity could serve as potential marker to guide DBS for Parkinson’s disease.
Drs. Steven DeKosky and Glenn Smith discuss Lecanemab for WUFT article.